| Schedule of Balance Sheets and the Results of Operations of the Company Classified as Discontinued Operations |
The assets and liabilities of disposal entities as of the respective date of disposal were as follows: | | | Hong Kong Subsidiary | | | Taiwan Subsidiary | | | | | As of December 31, 2025 | | | As of June 30, 2026 | | | | | US$ | | | US$ | | | | | | | | | | | Net assets disposal of: | | | | | | | | Cash | | | 5,926 | | | | 2,598,924 | | | Due from Advanced Biomed Inc. (Taiwan) | | | 438,720 | | | | - | | | Prepaid expenses and other current assets, net | | | 889,055 | | | | 49,989 | | | Equipment, net | | | 155,270 | | | | 97,023 | | | Right-of-use assets | | | - | | | | 32,432 | | | Other non-current assets, net | | | 214,497 | | | | - | | | Accounts payable, accruals, and other current liabilities | | | (299,904 | ) | | | (397,101 | ) | | Lease liabilities (current and non-current) | | | - | | | | (32,432 | ) | | Due to the Company | | | (6,432,919 | ) | | | (8,602,603 | ) | | Due to related parties of Hong Kong Subsidiary | | | (163,706 | ) | | | - | | | Due to Hong Kong Subsidiary | | | - | | | | (661,516 | ) | | Due to related parties of Taiwan Subsidiary | | | - | | | | (514,123 | ) | | Tax payable | | | (180 | ) | | | - | | | Total net liabilities disposed of | | | (5,193,241 | ) | | | (7,429,407 | ) | | | Hong Kong Subsidiary | | | Taiwan Subsidiary | | | Total | | | | US$ | | | US$ | | | US$ | | | | | | | | | | | | | | Gain on disposal of subsidiaries: | | | | | | | | | | | Total net liabilities disposed of | | | 5,193,241 | | | | 7,429,407 | | | | 12,622,648 | | | Release of the translation of subsidiaries in foreign currency charged to other comprehensive loss in prior periods | | | 450,526 | | | | 429,243 | | | | 879,769 | | | Cash consideration | | | 23,000 | | | | 490,000 | | | | 513,000 | | | | | 5,666,767 | | | | 8,348,650 | | | | 14,015,417 | | | | | | | | | | | | | | | | | Net cash inflow (outflow) arising from disposal | | | | | | | | | | | | | | Cash consideration received during the year | | | 23,000 | | | | - | | | | 23,000 | | | Cash disposed of | | | (5,926 | ) | | | (2,598,924 | ) | | | (2,604,850 | ) | | | | 17,074 | | | | (2,598,924 | ) | | | (2,581,850 | ) | The major classes of assets and liabilities of discontinued operation included in the consolidated balance sheets as of June 30, 2026 and 2025 were as follows: | | | As of | | | As of | | | | | June 30, 2026 | | | June 30, 2025 | | | | | US$ | | | US$ | | | Assets | | | | | | | | Current assets: | | | | | | | | Cash | | | — | | | | 2,872,776 | | | Prepaid expenses and other current assets, net | | | — | | | | 1,290,951 | | | Total current assets of discontinued operations | | | — | | | | 4,163,727 | | | | | | | | | | | | | Non-current assets: | | | | | | | | | | Equipment, net | | | — | | | | 331,346 | | | Right-of-use assets, net | | | — | | | | 65,399 | | | Other non-current assets, net | | | — | | | | 83,027 | | | Total non-current assets of discontinued operations | | | — | | | | 479,772 | | | Total assets of discontinued operations | | | — | | | | 4,643,499 | | | | | | | | | | | | | Liabilities | | | | | | | | | | Current liabilities: | | | | | | | | | | Accounts payable, accruals, and other current liabilities | | | — | | | | 2,072,486 | | | Amounts due to the Company | | | — | | | | 16,349,752 | | | Current lease payable | | | — | | | | 35,811 | | | Total current liabilities of discontinued operations | | | — | | | | 18,458,049 | | | | | | | | | | | | | Non-current liabilities: | | | | | | | | | | Non-current lease payable | | | — | | | | 5,879 | | | Amount due to related parties – non-current | | | — | | | | 69,797 | | | Total non-current liabilities of discontinued operations | | | | | | | 75,676 | | | Total liabilities of discontinued operations | | | — | | | | 18,533,725 | | The major components of the results of discontinued operations included in the consolidated statements of operations and comprehensive income (loss) for the years ended June 30, 2026 and 2025 were as follows: | | | For the Year Ended June 30, | | | | | 2026 | | | 2025 | | | | | US$ | | | US$ | | | Operating expenses: | | | | | | | | Research and development expenses | | | 869,823 | | | | 909,771 | | | General and administrative expenses | | | 443,126 | | | | 1,024,795 | | | Total operating expenses | | | 1,312,949 | | | | 1,934,566 | | | Operating loss | | | (1,312,949 | ) | | | (1,934,566 | ) | | | | | | | | | | | | Other income (expense): | | | | | | | | | | Interest income | | | 457 | | | | 24,915 | | | Other income (expense), net | | | 235,428 | | | | (262,848 | ) | | Total other income (expense), net | | | 235,885 | | | | (237,933 | ) | | Loss before tax expense | | | (1,077,064 | ) | | | (2,172,499 | ) | | Income tax expense | | | - | | | | - | | | Loss incurred in discontinued operations | | | (1,077,064 | ) | | | (2,172,499 | ) | | Gain on disposal of subsidiaries, net of tax | | | 14,015,417 | | | | - | | | Net income from discounted operations, net of tax | | | 12,938,353 | | | | (2,172,499 | ) |
|